AN2 Therapeutics, Inc.

NasdaqGS:ANTX Stock Report

Market Cap: US$40.0m

AN2 Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

AN2 Therapeutics has a total shareholder equity of $87.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $97.7M and $10.0M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$93.43m
EquityUS$87.67m
Total liabilitiesUS$10.02m
Total assetsUS$97.69m

Recent financial health updates

Recent updates

We're Keeping An Eye On AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

Nov 21
We're Keeping An Eye On AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

Is AN2 Therapeutics (NASDAQ:ANTX) In A Good Position To Invest In Growth?

Jul 04
Is AN2 Therapeutics (NASDAQ:ANTX) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Situation

Mar 23
Here's Why We're Not Too Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Situation

AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

Dec 05
AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

Aug 20
AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

May 09
We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

We're Not Very Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

Feb 03
We're Not Very Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

We're Hopeful That AN2 Therapeutics (NASDAQ:ANTX) Will Use Its Cash Wisely

Oct 21
We're Hopeful That AN2 Therapeutics (NASDAQ:ANTX) Will Use Its Cash Wisely

AN2 Therapeutics secures $17.8M contract from NIH

Sep 29

We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

Jul 01
We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

Financial Position Analysis

Short Term Liabilities: ANTX's short term assets ($97.7M) exceed its short term liabilities ($10.0M).

Long Term Liabilities: ANTX has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: ANTX is debt free.

Reducing Debt: ANTX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ANTX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ANTX has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 32.7% each year.


Discover healthy companies